Perrigo | PRGO - Zinsaufwendungen Für Schuld





Zinsaufwendungen Für Schuld Veränderung Datum
AbbVie USD 645M 69M 2026-03
Abbott USD 299M 231M 2026-06
Bayer EUR 675M 87M 2025-12
Bristol-Myers Squibb USD 407M 4M 2026-06
Coherus Biosciences USD 2.25M 76K 2025-12
Corcept Therapeutics USD 888.7M 73.82M 2026-06
Dr.Reddys Laboratories INR 1.26B 198M 2026-06
Eli Lilly USD 114.7M 134.3M 2025-09
J&J USD 43M 25M 2026-03
Merck USD 525M 46M 2026-06
Nestle CHF 862M 35M 2026-06
Pacira USD 3.62M 77K 2026-06
Perrigo USD 7.61B 373.8M 2026-06
Pfizer USD 667M 4M 2026-06
Phibro Animal Health USD 11.91M 191K 2025-12
Prestige Brands USD 13.94M 2.52M 2026-06
Reckitt Benckiser GBP 208M 198.3M 2024-12
Sanofi EUR 287M 109M 2026-06
Supernus Pharmaceuticals USD 910K 278K 2023-06
Teva Pharmaceutical Industries USD 195M 21M 2026-06
Xeris Pharmaceuticals USD 6.88M 269K 2026-03
Zoetis USD 61M 1000K 2026-06